The quest for effective treatments and management strategies for genetic disorders like Phenylketonuria (PKU) drives significant research in the biochemical and pharmaceutical fields. L-Phenylglycinol (CAS 3182-95-4), a chiral amino alcohol, has emerged as a compound of interest in this area due to its potential role in modulating amino acid absorption. For researchers and institutions exploring these avenues, understanding L-Phenylglycinol's properties and how to procure it is key.

Phenylketonuria is a metabolic disorder characterized by the body's inability to properly metabolize phenylalanine, an essential amino acid. High levels of phenylalanine can lead to severe intellectual disability and other health issues if left untreated. Research into methods that could reduce phenylalanine levels in the body, such as inhibiting its intestinal absorption, is an active area of study. L-Phenylglycinol has been investigated for its potential to act as such an inhibitor, offering a novel therapeutic approach.

As a chemical supplier, we recognize the importance of providing high-purity compounds that meet the demanding standards of biomedical research. L-Phenylglycinol (CAS 3182-95-4), typically supplied as a white to light yellow crystalline powder with a purity of 98.00% or higher, is crucial for experiments aiming to validate its therapeutic potential. Researchers seeking to buy L-Phenylglycinol for PKU-related studies need a reliable source that guarantees consistent quality and accurate specifications.

The unique structure of L-Phenylglycinol, with its amino and hydroxyl groups, along with its inherent chirality, makes it a specialized chemical. For institutions embarking on research projects, securing a consistent supply from a reputable L-Phenylglycinol manufacturer is vital. Establishing a partnership with a supplier that understands the needs of the research community, can provide detailed technical data, and offers a competitive L-Phenylglycinol price for research quantities, is highly advantageous.

While its primary use may be as a pharmaceutical intermediate, the investigation into L-Phenylglycinol's potential therapeutic applications, such as in the context of PKU management, underscores its significance in ongoing scientific discovery. As such, access to high-quality L-Phenylglycinol (CAS 3182-95-4) from dependable sources is critical for advancing this research.

In conclusion, L-Phenylglycinol (CAS 3182-95-4) holds promise in areas like Phenylketonuria research. For those needing to purchase this compound, focusing on purity, reliable suppliers, and clear communication regarding research needs will facilitate progress in this important scientific endeavor.